![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Norovirus vaccine from Moderna could have Phase 3 results this …
Jan 23, 2025 · Moderna is testing a norovirus vaccine in a phase three trial, with results available as soon as this year. Norovirus cases are on the rise this winter, with outbreaks already up …
Moderna Provides Update on Norovirus Vaccine Candidate
Jan 14, 2025 · Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial...
Moderna says it’s ‘one step closer’ to a norovirus ... - Yahoo
Jan 13, 2025 · Moderna is recruiting adult participants for Nova 301, its Phase 3 clinical trial evaluating an investigational norovirus vaccine called mRNA-1403. “Stomach bug,” “cruise-ship virus,” “winter...
A Norovirus Vaccine Is in the Works | TIME
Jan 10, 2025 · How close are we to having a norovirus vaccine? Moderna is currently enrolling 25,000 people around the world in a phase 3 trial of the shot, after earlier testing showed encouraging results. In ...
Moderna Announces First Participant Dosed in Pivotal Phase 3 …
Sep 30, 2024 · The vaccine candidate is a trivalent formulation containing mRNA that encodes for virus-like particles (VLPs) designed to protect against multiple norovirus genotypes. About Moderna. Moderna is a leader in the creation of the field of mRNA medicine.
Sick of the stomach bug? Moderna is making a norovirus vaccine
Jan 24, 2025 · Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.
From Covid to Norovirus: Moderna’s mRNA Tech Takes on
Jan 20, 2025 · Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent and sometimes dangerous source of food poisoning....
A genetic quirk protects some people from norovirus. Can vaccines ... - BBC
Dec 31, 2024 · Moderna have launched a clinical trial of a messenger RNA (mRNA) norovirus vaccine initially in 18-49 year olds and 60-80 year olds. Meanwhile, Boston-based biotech HilleVax is conducting...
Is a norovirus vaccine near? | The Week
Jan 9, 2025 · Moderna's norovirus inoculation uses the same mRNA technology that produced the company's revolutionary Covid-19 vaccines in 2020, which "use a genetic code to tell the body's cells to...
News Details - Moderna
Mar 27, 2024 · Moderna is advancing five vaccine candidates against viruses that cause latent infections, all of which are in clinical trials. When latent, a virus is present in the body but exists in a resting state, typically without causing any noticeable symptoms.